Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions

M.M. van Oers; M. Marek; O.W. Merten

Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions

M.M. van Oers (Inventor), M. Marek (Inventor), O.W. Merten (Inventor)

Research output: Patent

Abstract

The present invention relates to methods for the production of biopharmaceuticals implementing a baculovirus-based system. These methods advantageously allow the production of biopharmaceuticals with a reducednumber of orwithout contaminating baculoviral virions.

Original language	English
Patent number	WO2011020710
Priority date	17/08/09
Publication status	Published - 24 Feb 2011

Access to Document

https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=WO&NR=2011020710A2&KC=A2&FT=D&ND=4&date=20110224&DB=EPODOC&locale=en_EP

Cite this

@misc{87b0c46bb4ee47bca20ab023ad3ffe42,

title = "Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions",

abstract = "The present invention relates to methods for the production of biopharmaceuticals implementing a baculovirus-based system. These methods advantageously allow the production of biopharmaceuticals with a reducednumber of orwithout contaminating baculoviral virions.",

author = "{van Oers}, M.M. and M. Marek and O.W. Merten",

year = "2011",

month = feb,

day = "24",

language = "English",

type = "Patent",

note = "WO2011020710",

}

TY - PAT

T1 - Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions

AU - van Oers, M.M.

AU - Marek, M.

AU - Merten, O.W.

PY - 2011/2/24

Y1 - 2011/2/24

N2 - The present invention relates to methods for the production of biopharmaceuticals implementing a baculovirus-based system. These methods advantageously allow the production of biopharmaceuticals with a reducednumber of orwithout contaminating baculoviral virions.

AB - The present invention relates to methods for the production of biopharmaceuticals implementing a baculovirus-based system. These methods advantageously allow the production of biopharmaceuticals with a reducednumber of orwithout contaminating baculoviral virions.

M3 - Patent

M1 - WO2011020710

ER -

Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions

Abstract

Access to Document

Fingerprint

Cite this